| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.003 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |